Showing results (11-20 of 475) with videos related to

Sort By:
Pageof 48
Antiviral Therapy|December 3, 2008
The oncogenic potential of hepatitis B virus rtA181T/ surface truncation mutantMing-Wei Lai, Chau-Ting Yeh
Translational Oncology|December 21, 2024
ANGPTL3 overcomes sorafenib resistance via suppression of SNAI1 and CPT1A in liver cancerYang-Hsiang Lin, Cheng-Yi Chen, Hsiang-Cheng Chi, et al.
BMC Infectious Diseases|February 11, 2025
The ZNF717-rs2918520 genotype contributes to COVID-19 severity: a Taiwanese cohort studyYang-Hsiang Lin, Jen Yu, Yu-Chuan Teng, et al.
Frontiers in Medicine|June 13, 2020
Thyroid Hormone in Hepatocellular Carcinoma: Cancer Risk, Growth Regulation, and Anticancer Drug ResistanceYang-Hsiang Lin, Kwang-Huei Lin, Chau-Ting Yeh
Emerging Infectious Diseases|April 19, 2017
Phenotypic and Genotypic Shifts in Hepatitis B Virus in Treatment-Naive Patients, Taiwan, 2008-2012Chau-Ting Yeh, Kung-Hao Liang, Ming-Ling Chang, et al.
Hepatology International|August 9, 2018
Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot studyMing-Wei Lai, Chao-Wei Hsu, Chih-Lang Lin, et al.
International Journal of Molecular Sciences|September 5, 2020
Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated HIF1A, MGST2, and TGFbiMing-Wei Lai, Kung-Hao Liang, Chau-Ting Yeh
Pageof 48